Clearmind Medicine Inc (NASDAQ: CMND) has experienced a rise in its stock price by 5.54 compared to its previous closing price of 0.90. However, the company has seen a fall of -1.33% in its stock price over the last five trading days. globenewswire.com reported 2025-06-05 that CMND-100 has the potential to provide an innovative and advanced treatment option for hundreds of millions of people around the world afflicted with Alcohol Use Disorder
Is It Worth Investing in Clearmind Medicine Inc (NASDAQ: CMND) Right Now?
The 36-month beta value for CMND is at -1.31.
The public float for CMND is 2.97M, and currently, shorts hold a 5.50% of that float. The average trading volume for CMND on June 05, 2025 was 223.54K shares.
CMND’s Market Performance
CMND stock saw a decrease of -1.33% in the past week, with a monthly decline of -0.61% and a quarterly a decrease of -14.04%. The volatility ratio for the week is 1.97%, and the volatility levels for the last 30 days are 2.29% for Clearmind Medicine Inc (CMND). The simple moving average for the past 20 days is -2.14% for CMND’s stock, with a -24.01% simple moving average for the past 200 days.
CMND Trading at -3.87% from the 50-Day Moving Average
After a stumble in the market that brought CMND to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -58.52% of loss for the given period.
#####
#####
Stock Fundamentals for CMND
The total capital return value is set at -2.19. Equity return is now at value -125.61, with -59.45 for asset returns.
Based on Clearmind Medicine Inc (CMND), the company’s capital structure generated 0.02 points at debt to capital in total, while cash flow to debt ratio is standing at -101.54. The debt to equity ratio resting at 0.02. The interest coverage ratio of the stock is -139.39.
Currently, EBITDA for the company is -5.85 million with net debt to EBITDA at 1.08. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.72.
Conclusion
In conclusion, Clearmind Medicine Inc (CMND) has had a bad performance lately. Opinion on the stock among analysts is mixed, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
